PCK 6.67% 2.8¢ painchek ltd

FDA De Novo approval date for Painchek's Dementia App, page-2

  1. 6,794 Posts.
    lightbulb Created with Sketch. 4496
    You shouldn't use ResApp as a yardstick here. They failed in their US trial miserably thereby knocking their reputation to kingdom high. Any regulatory body would be extra careful with their claim after that. Even their CE Mark application seems to take forever while ours just came out of thin air.

    But having said all that, your enquiry is the million dollar question here. FDA is the holy grail of all approval. I understand that the requirements are complex and complicated. We just have to be patient. It won't be easy but well worth it once it is obtained. And FYI, the management seems to expect approval by early 2020.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
-0.002(6.67%)
Mkt cap ! $47.48M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $7.462K 257.5K

Buyers (Bids)

No. Vol. Price($)
4 851941 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 783131 1
View Market Depth
Last trade - 14.48pm 18/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.